210 related articles for article (PubMed ID: 23887848)
1. Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer.
Emoto S; Yamaguchi H; Kamei T; Ishigami H; Suhara T; Suzuki Y; Ito T; Kitayama J; Watanabe T
Surg Today; 2014 May; 44(5):919-26. PubMed ID: 23887848
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal Delivery of Cisplatin via a Hyaluronan-Based Nanogel/in Situ Cross-Linkable Hydrogel Hybrid System for Peritoneal Dissemination of Gastric Cancer.
Ohta S; Hiramoto S; Amano Y; Emoto S; Yamaguchi H; Ishigami H; Kitayama J; Ito T
Mol Pharm; 2017 Sep; 14(9):3105-3113. PubMed ID: 28806513
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal chemotherapy for peritoneal metastases using sustained release formula of cisplatin-incorporated gelatin hydrogel granules.
Yamashita K; Tsunoda S; Gunji S; Murakami T; Suzuki T; Tabata Y; Sakai Y
Surg Today; 2019 Sep; 49(9):785-794. PubMed ID: 30847629
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal Administration of a Cisplatin-Loaded Nanogel through a Hybrid System Containing an Alginic Acid-Based Nanogel and an
Yamaguchi K; Hiraike O; Iwaki H; Matsumiya K; Nakamura N; Sone K; Ohta S; Osuga Y; Ito T
Mol Pharm; 2021 Nov; 18(11):4090-4098. PubMed ID: 34662129
[TBL] [Abstract][Full Text] [Related]
5. A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin.
Gunji S; Obama K; Matsui M; Tabata Y; Sakai Y
Surgery; 2013 Nov; 154(5):991-9. PubMed ID: 24008088
[TBL] [Abstract][Full Text] [Related]
6. Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer.
Iinuma H; Maruyama K; Okinaga K; Sasaki K; Sekine T; Ishida O; Ogiwara N; Johkura K; Yonemura Y
Int J Cancer; 2002 May; 99(1):130-7. PubMed ID: 11948504
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal administration of biocompatible hyaluronic acid hydrogel containing multi-chemotherapeutic agents for treatment of colorectal peritoneal carcinomatosis.
Luo J; Wu Z; Lu Y; Xiong K; Wen Q; Zhao L; Wang B; Gui Y; Fu S
Int J Biol Macromol; 2020 Jun; 152():718-726. PubMed ID: 32126201
[TBL] [Abstract][Full Text] [Related]
8. [Effect of intraperitoneal chemotherapy on experimental peritoneal dissemination of gastric cancer].
Yonemura Y; Endou Y; Tochiori S; Bando E; Kawamura T; Shimada T; Miyamoto K; Tanaka M; Sasaki T
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1635-9. PubMed ID: 16315893
[TBL] [Abstract][Full Text] [Related]
9. [An effective treatment by chemotherapy with S-1 and CDDP intraperitoneal administration for the peritoneal dissemination of gastric cancer--a case report].
Kadono M; Iwasaki Y; Ohashi M; Iwanaga T; Ohinata R; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2442-4. PubMed ID: 21224600
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and antitumoral effect of long-circulating and pH-sensitive liposomal cisplatin administered in Ehrlich tumor-bearing mice.
Araújo JG; Mota Ld; Leite EA; Maroni Lde C; Wainstein AJ; Coelho LG; Savassi-Rocha PR; Pereira MT; de Carvalho AT; Cardoso VN; De Oliveira MC
Exp Biol Med (Maywood); 2011 Jul; 236(7):808-15. PubMed ID: 21685237
[TBL] [Abstract][Full Text] [Related]
11. Use of 5-Fluorouracil Loaded Micelles and Cisplatin in Thermosensitive Chitosan Hydrogel as an Efficient Therapy against Colorectal Peritoneal Carcinomatosis.
Yun Q; Wang SS; Xu S; Yang JP; Fan J; Yang LL; Chen Y; Fu SZ; Wu JB
Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27762505
[TBL] [Abstract][Full Text] [Related]
12. The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model.
Yu J; Lee HJ; Hur K; Kwak MK; Han TS; Kim WH; Song SC; Yanagihara K; Yang HK
Invest New Drugs; 2012 Feb; 30(1):1-7. PubMed ID: 20669041
[TBL] [Abstract][Full Text] [Related]
13. [The significance of low-dose CDDP intraperitoneal administration for cases of peritoneal dissemination of gastric cancer].
Ninomiya M; Sasaki H; Yano S; Harano M; Aoki H; Onoda T; Shiozaki S; Ohno S; Higaki K; Kobayashi N; Takakura N
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1717-9. PubMed ID: 15553693
[TBL] [Abstract][Full Text] [Related]
14. Thermosensitive Injectable Hydrogel for Simultaneous Intraperitoneal Delivery of Doxorubicin and Prevention of Peritoneal Adhesion.
Chen CH; Kuo CY; Chen SH; Mao SH; Chang CY; Shalumon KT; Chen JP
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734717
[TBL] [Abstract][Full Text] [Related]
15. CD44-targeted microparticles for delivery of cisplatin to peritoneal metastases.
Li SD; Howell SB
Mol Pharm; 2010 Feb; 7(1):280-90. PubMed ID: 19994852
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics following intraperitoneal sequential administration of cisplatin and fluorouracil for gastric cancer].
Hiratsuka M; Furukawa H; Iwanaga T; Nakamori S; Masutani S; Ohigashi H; Kameyama M; Sasaki Y; Kabuto T; Ishikawa O
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1627-30. PubMed ID: 8373234
[TBL] [Abstract][Full Text] [Related]
17. [Safety and efficacy of hypotonic CDDP intraperitoneal administration for gastric cancer with peritoneal dissemination].
Bamba T; Kanda T; Ohashi M; Hanyu T; Sakamoto K; Ishikawa T; Yajima K; Makino S; Tanabe T; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1695-7. PubMed ID: 16315912
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic analysis of intra-peritoneal administration of cisplatin].
Terashima M; Ikeda K; Takagane A; Sasaki N; Abe K; Araya M; Nishizuka S; Yonezawa H; Irinoda T; Nakaya T; Oyama K; Saito K
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1859-62. PubMed ID: 9382551
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer.
Bae WK; Park MS; Lee JH; Hwang JE; Shim HJ; Cho SH; Kim DE; Ko HM; Cho CS; Park IK; Chung IJ
Biomaterials; 2013 Jan; 34(4):1433-41. PubMed ID: 23174142
[TBL] [Abstract][Full Text] [Related]
20. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity.
Yang F; Li A; Liu H; Zhang H
Drug Des Devel Ther; 2018; 12():3321-3333. PubMed ID: 30323564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
